utilizing business acumen, communication, and

6
Utilizing Business Acumen, Communication, and Interpersonal Skills to Drive Success The ONLY online conference for MSLs, offering strategies you can’t find anywhere else! • Performance Metrics and KPIs That Demonstrate Value to an Organization • Innovative Ways to Upskill and Build a Successful Career • Guides for Nourishing Communication Techniques and Soft Skills to Effectively Engage with Stakeholders • Clarifying the Impact of Business Acumen on Successful KOL Engagements • Best Practices and Compliant Strategies for Aligning Medical Affairs with Clinical Development and Commercial Teams June 23-24, 2021 | Online Livestream Kent Christopherson Senior National Director, US Medical Affairs Orchard Therapeutics Johan Baeck Senior Vice President, Clinical Development and Medical Affairs Jounce Therapeutics Ruth Du Moulin Vice President, Medical Affairs FORMA Therapeutics Jacqueline Dessibourg Regional Medical Director Santhera Charlie Cook Director, Field Medical Gastroenterology Takeda Christiane Carney Medical Science Liaison Taiho Oncology Gaby Cora Field Medical Director, North America Medical Affairs Pfizer Keely Dahl Senior Medical Science Liaison Aurinia Pharmaceuticals Sunayana (Nina) Banerjee Senior Medical Science Liaison Jazz Pharmaceuticals Deirdre De Steno Head of Global Medical Affairs Diagnostics Grifols Jacqueline Armani Regional Director, Medical Science Liaison Alcon Jay Dave Associate Director, Medical Science Liaison Novartis

Upload: others

Post on 17-Mar-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Utilizing Business Acumen, Communication, and Interpersonal Skills to Drive Success

The ONLY online conference for MSLs, offering strategies you can’t find anywhere else!

• Performance Metrics and KPIs That Demonstrate Value to an Organization• Innovative Ways to Upskill and Build a Successful Career• Guides for Nourishing Communication Techniques and Soft Skills to Effectively Engage with Stakeholders• Clarifying the Impact of Business Acumen on Successful KOL Engagements• Best Practices and Compliant Strategies for Aligning Medical Affairs with Clinical Development and

Commercial Teams

June 23-24, 2021 | Online Livestream

Kent Christopherson

Senior National Director, US Medical AffairsOrchard Therapeutics

Johan Baeck

Senior Vice President, Clinical Development and Medical AffairsJounce Therapeutics

Ruth Du Moulin

Vice President, Medical AffairsFORMA Therapeutics

Jacqueline Dessibourg

Regional Medical DirectorSanthera

Charlie Cook

Director, Field MedicalGastroenterologyTakeda

Christiane Carney

Medical Science LiaisonTaiho Oncology

Gaby Cora

Field Medical Director, North America Medical AffairsPfizer

Keely Dahl

Senior Medical Science LiaisonAurinia Pharmaceuticals

Sunayana (Nina) Banerjee

Senior Medical Science LiaisonJazz Pharmaceuticals

Deirdre De Steno

Head of Global Medical Affairs DiagnosticsGrifols

Jacqueline Armani

Regional Director, Medical ScienceLiaison Alcon

Jay Dave

Associate Director, Medical Science LiaisonNovartis

MSLs are vital to the success of drug and device development. They work throughout a product’slifecycle to help ensure that products are utilized effectively, serve as scientific peers and resourceswithin the medical community, and are scientific experts to internal colleagues.  And just like the rest ofthe life science sector, MSLs have to rapidly adjust to the rollout of new technology platforms and re-envision their workload in post-COVID conditions. 

DGE invites you to its inaugural Next-Gen MSL Excellence Symposium – the only industry event tospecifically focus on overcoming the daily work challenges for this essential group, while reaching careermilestones and adapting to new technologies!

Who Should Attend

This Virtual Event Will Also Benefit:

• Medical Science Liaisons (MSL)• Medical Director/Advisor• Field Medical Director• Medical Scientific Manager• Medical Excellence• Clinical Trial Liaison (CTL)

• MSL Talent Providers• KOL/Thought Leader Engagement System Providers

• Physician Network Solutions• AI Solutions for MSLs and Management

June 23-24, 2021 | Online Livestream

• Medical Affairs• KOL/Thought Leader Engagement• Medical Communication/Information• Product Lifecycle Management• Clinical/Scientific Affairs• Compliance

REGISTER

June 23-24, 2021 | Online Livestream

Kent Christopherson

Senior National Director, US Medical AffairsOrchard Therapeutics

Johan Baeck

Senior Vice President, Clinical Development and Medical AffairsJounce Therapeutics

Eva Gallagher

Vice President, Head of Medical AffairsAgios Pharmaceuticals

Ruth Du Moulin

Vice President, Medical AffairsFORMA Therapeutics

Jacqueline Dessibourg

Regional Medical DirectorSanthera

Donna Holder

Senior Director, Global MSL Excellence OncologyDaiichi Sankyo

Erin Gleason

Director, Medical Operations, Information, and Trainingbluebird bio

Ajit Kulkarni

Ad-interim Director of Field Medical CapabilitiesNovartis

Ed Paiewonsky

Senior Managed Care LiaisonNeurocrine Biosciences

Eddie Power

Vice President, North America Medical AffairsPfizer

Bob Fell

Executive Medical Science LiaisonSanofi

Charlie Cook

Director, Field MedicalGastroenterologyTakeda

Christiane Carney

Medical Science LiaisonTaiho Oncology

Desiree Owen

Director, Medical Science LiaisonsKala Pharmaceuticals

Gaby Cora

Field Medical Director, North America Medical AffairsPfizer

Irma Saliu

National Director, Psychiatry Medical Science LiaisonsAbbVie

Keely Dahl

Senior Medical Science LiaisonAurinia Pharmaceuticals

Kent Gordon

Manager, Medical Science Liaisons - North AmericaBioventus

Sunayana (Nina) Banerjee

Senior Medical Science LiaisonJazz Pharmaceuticals

Zachary Henney

Director, Medical Science LiaisonChiasma

Susan Giacalone

National Director, Field Medical AffairsMacroGenics

Deirdre De Steno

Head of Global Medical Affairs DiagnosticsGrifols

Jacqueline Armani

Regional Director, Medical ScienceLiaison Alcon

C. Rick Jarecke

Senior Director, Field Medical Affairs Science LiaisonsUrovant Sciences

Sheila Komara

Senior Medical Science LiaisonMallinckrodt

Jay Dave

Associate Director, Medical Science LiaisonNovartis

Nancy Ortiz

Executive Director, Global Medical Affairs & Field MedicalStrongbridge Biopharma

Susan Malecha

Senior Director, Medical AffairsPuma Biotechnology

Elizabeth Martinez

Executive Director, Global Medical AffairsCuris

REGISTER

9:00 AM EST

10:00 – 10:15 AM

10:15 – 11:00 AM

Login

1:30 – 2:00 PM Lunch

4:15 PM Day One Concludes

Introduction from Chairperson

Panel: Build Stronger Business Acumen

PART 1: DEVELOPING MSL SKILLS AND IMPROVING CAREER PATHS

With rising drug and device cost, MSLs are challenged with thinking on an enterprise level and understanding the factors that impact how a health care provider, hospital system or patient makes decisions.

• Define the factors that drive key stakeholder decisions• Develop a communication plan to personalize the message • Treat your territory like a business and representing your company without selling

Moderator:Susan MalechaSenior Director, Medical AffairsPuma Biotechnology

Speakers:Jacqueline DessibourgRegional Medical DirectorSanthera

Susan GiacaloneNational Director, Field Medical AffairsMacroGenics

Ed PaiewonskySenior Managed Care LiaisonNeurocrine Biosciences

11:00 – 11:45 AM Turn Science into a Compelling Story

MSLs are experts in communicating complex scientific data but HCPs now want more patient centric communications to support their decisions.

• Understand the needs of an HCP and what drives their decisions• Develop content that engages KOLs and encourages them to ask questions and provide insights• Reshape data into narratives without sacrificing accuracy

Kent Gordon Manager, Medical Science Liaisons - North America Bioventus

2:00 – 2:45 PM Envision Life After a Layoff

Despite the anxiety and uncertainty associated with a layoff, there are many opportunities to getting your career back on track.

• Discuss the emotional impact of a layoff• Craft a plan that ensures financial security• Uncover opportunities to engage with recruiters and network within the industry

Keely Dahl Senior Medical Science LiaisonAurinia Pharmaceuticals

2:45 – 3:30 PM Panel: Select Ideal Metrics for MSL Value

MSLs are vital to a company’s medical affairs strategy and the impact they have can be defined by more than just numbers. Quantitative metrics are easily measured – but how do we gauge the qualitative metrics that demonstrate the impact of an MSLs on the overall success of a company?

• Identify the activity-driven metrics that will continue to be a performance indicator• Discuss the steps that medical affairs leaders are taking to align quantitative metrics with qualitative ones • Discuss the challenges in adopting new metrics and impact on the industry as a whole

Moderator: Ruth Du MoulinVice President, Medical AffairsFORMA Therapeutics

Speakers: Charlie CookDirector, Field Medical GastroenterologyTakeda

Erin GleasonDirector, Medical Operations, Information, and Trainingbluebird bio

3:30 – 4:15 PM Own Your Professional Development Path

Investing in your career empowers you to create the future you want. Would you invest in your own professional development or are you waiting for your company to provide you with opportunities for growth?

• Uncover opportunities for learning and growth within your company• Form a professional development plan that adds value to your future as well as your company’s future• Craft effective approaches to presenting your development plan to leadership.

Ajit Kulkarni Ad-interim Director of Field Medical Capabilities Novartis

12:00 – 12:45 AM Panel: Avoid Burnout and Maximize Energy in a Remote Environment

Work-life balance is something that MSLs have been challenged with throughout their careers. The pandemic brought to light new challenges surrounding one of the fast-growing professional obstacles: Burnout.

• Define workplace burnout and its impact on MSLs• Manage your energy as well as your time• Create balance and satisfaction in your life

Moderator: Gaby CoraField Medical Director, North America Medical AffairsPfizer

Speakers: Christiane CarneyMedical Science LiaisonTaiho Oncology

Bob FellExecutive Medical Science LiaisonSanofi

12:45 – 1:30 PM Panel: Build a Successful MSL Career: Challenges and Opportunities to Upskill

Although MSLs are experts in their therapeutic area, there are many opportunities for upskilling and adapting to change.

• Determine how your professional goals align with the needs of the company• Identify ways to influence without power• Recognize how you fit into the culture of your team and the philosophy of the company• Develop relationships and comradery in the virtual space

Speakers: Jay DaveAssociate Director, Medical Science LiaisonNovartis

Donna HolderSenior Director, Global MSL Excellence OncologyDaiichi Sankyo

Irma SaliuNational Director, Psychiatry Medical Science LiaisonsAbbVie

11:45 – 12:00 PM Networking Break

All times are in EST

June 23-24, 2021 | Online LivestreamREGISTER

June 23-24, 2021 | Online Livestream

9:00 AM EST

10:00 – 10:15 AM

10:15 – 11:00 AM

Login

11:45 – 12:00 PM Networking Break

Chairperson’s Recap of Day One

Envision Future Career Opportunities for MSLs

When you are ready for that next step in your career, what opportunities are available at different stages of your career and what challenges might you run into? Meeting career goals may require cultivating or advertising additional skills.

• Map out opportunities to transition in a therapeutic area you desire • Understand the challenges in switching therapeutic areas • Transition into from a field role to an in-house role• Embrace the dynamic shift when moving from a large team to a smaller team

Eva Gallagher Vice President, Head of Medical AffairsAgios Pharmaceuticals

11:00 – 11:45 AMAdapt Your Field Medical Affairs Team to

New & Expanding Roles

MSLs were once defined by the relationships they build with KOLs and their ability to educate using scientific data. But as the landscape of healthcare has seismically shifted, MSLs are increasingly tasked with a board variety of new responsibilities, each needing their own expertise and training.

• Understand medical affairs organizational structure in the context of internal and external stakeholders • Leverage the field medical affairs team to engage providers, payers, and patient advocacy• Maximize the impact of the field medical affairs team though in-depth knowledge and understanding

Kent Christopherson Senior National Director, US Medical AffairsOrchard Therapeutics

Desiree Owen Director, Medical Science LiaisonsKala Pharmaceuticals

12:00 – 12:45 PMEstablish Best Practices and Compliant Strategies

for Working with Clinical Development Teams

There has been a massive shift in MSL involvement with clinical trials. Until recently, MSLs were only involved in products that were approved or in late-stage trials. Many companies are now engaging MSLs in early clinical development which presents a unique set of challenges but also an opportunity for growth.

• Understand the need and impact of involving MSLs in early clinical development• Create synergies between clinical development and medical affairs teams • Define the skills and education MSLs will need to embrace and excel in this new paradigm

Johan Baeck Senior Vice President, Clinical Development and Medical AffairsJounce Therapeutics

Elizabeth Martinez Executive Director, Global Medical Affairs Curis

REGISTER

2:00 – 2:45 PMAlign Medical Affairs Teams with

Commercial Counterparts

MSLs have an opportunity to collaborate with their commercial counterparts to provide HCPs with a unified final experience. What steps are required to balance the messaging and encourage a compliant partnership.

• Identify the SOPs that have been established for your medical affairs team• Break the silos between medical affairs and commercial teams• Understand what compliance looks like in a virtual setting• Educate HCPs on the differences between MSLs and sales teams

Deirdre De StenoHead of Global Medical Affairs DiagnosticsGrifols

Zachary HenneyDirector, Medical Science LiaisonChiasma

2:45 – 3:30 PMLaunch a New Product During the Pandemic –

The Good, the Bad, and the Unknown

Launching a new product or breaking into a new indication has its challenges – moreso during a pandemic. What can we learn from those who are have done it and ready ourselves for the future?

• Educate yourself on the new product and identifying those new KOLs• Set strategies for standing out and presenting data that is compelling• Overcome the hurdles amplified during the pandemic

Speakers: Jacqueline ArmaniRegional Director, Medical Science LiaisonAlcon

Sunayana (Nina) BanerjeeSenior Medical Science LiaisonJazz Pharmaceuticals

Sheila KomaraSenior Medical Science LiaisonMallinckrodt

12:45 – 1:30 PMPanel: Debate How to Structure In-Person,

Virtual, and Hybrid Engagements

Join our panelists as they discuss future of MSL engagements and the merits of each scenario.

• Review achievability and practical pros and cons of hybrid engagements• Evaluate impact of each scenario on an MSLs metrics• Anticipate different impacts on product success

Speakers: C. Rick JareckeSenior Director, Field Medical Affairs Science LiaisonsUrovant Sciences

Nancy OrtizExecutive Director, Global Medical Affairs & Field MedicalStrongbridge Biopharma

Eddie PowerVice President, North America Medical AffairsPfizer

1:30 – 2:00 PM Lunch

Conference Concludes

PART 2: IMPROVING ENGAGEMENT AND COLLABORATION WITH KEY STAKEHOLDERS

All times are in EST

June 23-24, 2021 | Online Livestream

EARLY BIRD

($996.00)(REGISTER BY MAY 14, 2021)

STANDARD

($1,196.00)(REGISTER BY MAY 14, 2021)

PRICES:

SPONSORED BY:

MEDIA PARTNERS

REGISTER

REGISTER NOW | GROUP DISCOUNTS AVAILABLE!

Register 2 attendees, get 1 complimentary. Interested in groups of 7 or more? Special pricing and packages are available.

CLICK HERE TO REGISTER

Get your group to attend the seminar at a discounted price call +1-201-871-0474.or Fax your PO: 253-663-7224Pay by check to PMA Conference Management, 405 Highview Rd, Englewood NJ 07631.